Click on headlines below to download research

SDC-1801 CTA application hits a roadblock
Sareum Holdings | 09/11/2022

Sareum has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has turned down the clinical trial authorisation (CTA) for…

SDC-1801 poised for the clinic
Sareum Holdings | 25/10/2022

Sareum’s FY22 results (to end-June 2022) provided both a financial and operational update on the company’s progress with its developmental…

Sierra Oncology returns rights to SRA737
Sareum Holdings | 12/10/2022

Sareum has announced that Sierra Oncology has decided to return the rights to the out-licensed CHK1 asset SRA737 (held in partnership with the CRT Pioneer…